Study Details
CSL-964
(IRB#: IRB_00125273)
A study to evaluate the safety and efficacy of Alpha 1 Antitrypsin for the prevention of graft versus host disease in patients receiving hematopoietic cell transplant
- All genders
- Over 7 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 7 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes
IRB#: IRB_00125273
PI: AHMAD RAYES
Department: UNIVERSITY OF UTAH (PRESIDENT)
Approval Date: 2020-07-01 06:00:00
Study Categories: Cancer Studies
Specialties: Pediatric Hematology & Oncology